ARCHIVES

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

Senate Vote On Override Of NIH Reauthorization Veto Delayed Until After US-USSR Summit Meeting

November 22, 1985

In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI

September 13, 1985

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

October 1, 1993

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof

March 21, 1997